Skip to main content

Table 1 Patient responses

From: Dendritic cell vaccine treatment for indolent B cell non-hodgkin lymphoma: clinical trial in progress

Arm ID Age/
Gender
Histology Stage FLIPI/IPI # of prior Tx DC doses Best response Time to next treatment or event (months)
A LSA1 57M Follicular IVA 2 1 2 SD 25
A LSA2 56F Follicular IIIB 4 2 2 SD 14
A LSA3 69M Follicular IVA 3 4 2 PR 22
A LSA4 60F Follicular IVA 3 3 2 PR 20
A LSA5 64F Follicular IVA 5 8 8 PR Not reached (12 mo at the time of abstract.)
A LSA6 81M Follicular IVA 4 1 8 SD Not reached (9 mo at the time of abstract.)
B LSB1 60M Follicular IIIA 3 1 4 SD 6.5
B LSB2 62F Marginal zone IVAE 4 6 4 SD 7.6
B LSB3 65F Follicular IVA 3 2 8 CR Not reached (13 mo at the time of abstract.)
B LSB4 31F Follicular IIIA 2 0 8 PR Not reached (12 mo at the time of abstract.)